chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse consumer concerning her daughter currently 32 years old with unspecified drug reactions/allergies and medical history, who when she was a 13 year old on 18-APR-1991 was vaccinated with a booster of MMR II (route and lot number unspecified). Suspect vaccine included a first dose of "monovalents vaccines" of MMR II (manufacturer unspecified, route and lot number unspecified). It was reported that the patient originally started with "monovalent vaccine" and she did not received MMR II until booster. The registered nurse mother reported that her daughter one week after received a booster menses and after another week developed petichiae. On an unspecified date, the patient went to her physician and the following laboratories were performed: blood count and a bone marrow aspiration (results unspecified) and the patient was diagnosed with thrombocytopenia. The patient was treated with prednisone and globulin, immune therapy (IVIG) until 12-JUN-1997, when she had a splenectomy. The patient was hospitalized (date unspecified). Thorombocytopenia was considered immediately life-threatening, disabling and other important medical event by the consumer. At the time of the report the outcome of the patient was unknown. Follow up information has been received from a Registered Nurse who reported that the patient first seen by the physician on 02-JUL-1991 and the following laboratories were performed: Blood work drawn and showed a platelet count of 20 (NR-150-400) and a bone marrow aspiration that revealed immune thrombocytopenia purpura. The patient was treated with prednisone and immune therapy (IVIG); By 10-JUL-1991, the patient's platelets were back up to 220 patient's splenectomy was performed on 12-JUN-1997 (not in 1987). In 2002, the patient visited the physician and a platelet count at that time was 507 and considered recovered. According with the nurse, the physician felt that event was not related to the MMR II vaccine. The health care professional contacted during telephone follow-up could not supply the following information: lot number and hospital name. No further information is available.
p/vax pt states lt arm is painful to touch & motion;also states there is a lump @ site of inj;instructed to apply warm compress to area & cont OTC pain reliever as needed;
Fever, cough, "red dots on me" (trunk, arms, legs), painful muscles, joint, pt reports " my whole body aches ". Pt reports seizure.
I lost the hearing in my left ear; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1(manufacturer unknown)), for Covid-19 immunization; Covid-19 vaccine (Dose 2(manufacturer unknown)), for Covid-19 immunization. The following information was reported: DEAFNESS (medically significant), outcome "unknown", described as "I lost the hearing in my left ear". The event "i lost the hearing in my left ear" required physician office visit. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Immediately after injection, left arm at injection site was painful to touch, not just sore.  2 days later, that had stopped.  On  1/26/21, my left arm at the injection site started to be slightly itchy. The following morning, the area was constantly itching. That evening, I looked at my left arm at the site, and I have broken out in hives, the muscle is swollen and warm and I am having to take an antihistamine twice a day so it does not itch but it continues to be red, itchy and swollen.
Pt received 4 yo immunization in bilateral legs. Seen again 3 d later after developed redness, bruising, itching and warmth to area. No fever. Pt treated with Benadryl for reaction and Cephalexin 350/5 2 tsp PO 7d for possible cellulitis.
This spontaneous report was received from a physician refers to a 14 year old male patient. Information on the patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL 9 (dosing details, batch/lot number unspecified) for prophylaxis. On 17-AUG-2018 the patient had fever and flu like symptoms. The patient was under observation for thirty to sixty minutes in the office. Outcome of pyrexia and influenza like illness was unknown. Causality assessment was not reported. No product quality complaint involved.
I spoke to the patient, she said that the vaccine did not hurt that much on injection, but lter that day and for the next couple of days, it hurt alot. Her arm still hurts, but is in an ache at certain times. Last night, it really hurt a lot and throbbed all night. It kept her awake.
Immediate bruise at injection; rash/redness around area within 15 minutes. Patient complaining of joint aching.
Fever of 101.2F; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.2F) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A211A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PYREXIA (Fever of 101.2F). At the time of the report, PYREXIA (Fever of 101.2F) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Body temperature: 101.2 (High) 101.2 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.
Uncontrollable diarreah, achiness in joints, and unable to remember things as usual.
by mistake instead of picking up from the refrigerator the prefilled syringes with Pfizer vaccine I picked up the Moderna vaccine. Moderna not authorized as yet for 15 year old. I called the Moderna reporting line as well as DOH.
a patient presented and requested a rabies vaccine 0.5ml was administered for puppy bite but  previously vaccinated with the vaccoine was not pre-exposure prophylaxis; Initial information received on 22-May-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 27 year old male patient who previously vaccinated but that was not pre-exposure prophylaxis, and then received RABIES (HDC) VACCINE [IMOVAX RABIES]. It turns out that the consumer was trying to treat a dog bite.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 19-May-2019, the patient received a 0.5 ml dose of suspect RABIES (HDC) VACCINE (formulation: unknown, lot: N1L13 expiry date: 14-Nov-2019) via intramuscular route in the left arm.  It was an actual medication error due to Inappropriate schedule of vaccine administered.   It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.; Sender's Comments: This case was considered valid only so that we can query regarding the schedule followed in this patient. In case no deviation from schedule is reported on a later date, case will be downgraded.
Pt reported feelings of tightness in throat, difficulty swallowing, tingling in face, and feeling warm. Vital signs obtained, O2 99%, HR 100-107, BP 133/81. Pt was able to drink water comfortably. Did not appear in any respiratory distress, no angioedema noted. Cetirizine administered. Pt was brought to ED via wheelchair accompanied by RN for further evaluation.
Unknown vaccination dates, manufacturer of vaccine, and actual adverse event dates. Patient reported that he had lymphoma that was in remission since 2010. Reported after his 2nd covid shot his "glands started swelling." Reported after his booster, "it was full-blown cancer again." Now undergoing treatment for lymphoma.
Neck became really sore, as if I had bad whiplash, from September - December.  Its not entirely better, but has definitely turned a corner and feeling better every day.  Reporting "neck inflammation" only because I know heart inflammation has been an issue and want this data available if VAERS if the issue is more inflammation in general rather than heart specific.
Patient had substantial redness around the injection site, he stated roughly 55 square centimeters.  Also had soreness of the arm and chills the night of the vaccination. He also reported perhaps some nausea just briefly. His arm is still sore now; however, he stated that it's much better now.
4/7/21. Sweating profusely,no fever.  4/8/21 .Swollen left upper arm (2× it's size).Intense itching entire left arm for 24 hours
(REPORTED BY HOSPITAL) 104-105 FEVERS, BODY ACHES AND OTHER FLU LIKE SYMPTOMS.  HIVE LIKE RASH TO FACE 10/29/09:  ED Records received for date of service 10/23/09.  Dx:  Acute febrile influenza like illness. Assessment:  Presented to the ED with fever of 104 degrees, influenza-type syndrome including body aches and a runny nose, decreased appetite, decreased fluid intake, blotchy rash on face, intermittent swelling of hands and feet. Admitted to the hospital for IV hydration and management of fever.     11/13/09:  Discharge Summary received for dates of service 10/26/09 to 10/28/09:  Final Dx:  Influenza A, probable H1N1 flu; intractable fever.   Assessment:  Admitted for high fever and dehydration.  Hydrated with IV fluids and started on Tamiflu as well as ceftriaxone for possible beginnings of pneumonia.  Discharged afebrile and doing well./
Client received first dose Moderna  Left Deltoid Lot 031M20A on 2/13/2021
Information has been received as part of a class action suit concerning a female who was vaccinated with hepatitis B immune globulin. Subsequently the patient's son experienced neurological disorder and mercury poisoning. Upon internal review neurological disorder and mercury poisoning were considered other important medical events (OMIC). No further information is available. This report was received from the manufacturer's legal department on 12/21/04. Per follow up report received on 06/14/2005:  Patient's recovery status is still unknown.
Sudden onset of tinnitus about 2 months after my last Covid-19 vaccination.
16:30 admin: 19:30 arm very tender, hurt to move it; 21:30 chills, shaking.  Ice on it, ibuprofen and went to bed. Next day still felt lousy, kept prescription off and on-no fever; swollen and red all way down to elbow.  Still warm and swollen x2 days later; gradual return to normal.
Experienced shortness of breath from the next day after my 2nd dose of Pfizer vaccination.; a very high heart rate (resting heart rate was 110 reaching up to 150)/Heart rate was going 130 - 150; This is a spontaneous report from a contactable consumer (patient). A 43-years-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 01May2021 (Batch/Lot Number: PFIZEREWO167) as 2ND DOSE, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. Medical history included thyroid. Concomitant medication (patient received within 2 weeks of vaccination) included levothyroxine sodium (THYROX) taken for an unspecified indication, start and stop date were not reported. The patient previous took first dose of BNT162B2 on 10Apr2021 at 04:45 PM (Lot number: PFIZEREWO161) administered in left arm for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced shortness of breath from the next day after her 2nd dose of Pfizer vaccination (02May2021). A severe shortness of breath with a very high heart rate (resting heart rate was 110 reaching up to 150) after 2nd dose of Pfizer vaccination started on 02May2021. Symptoms were getting worse, got admitted in Emergency Hospital on 07May2021. As it was worsening day by day and the Heart rate was going 130 - 150, had to admit in Emergency room on 07May2021. All the test reports appeared negative. Patient had thyroid and was within range. Patient didn't see any reason of such a severe shortness of breath other than reaction of vaccination. The adverse event result in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. When asking what treatment received for the adverse event, 'Please reach out to (withheld)'. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was recovering. The reporter classified the events as serious with Seriousness criteria - Life threatening and Caused/prolonged hospitalization.   Information on the lot/batch number has been requested.
PATIENT RECEIVED FLU-VACCINE AND DEVELOPED A RASH // MD TREATED PATIENT WITH CLARITIN DAILY FOR 5 DAYS
Information has been received from a medical assistant concerning a 15 month old male with penicillin allergy who on 14-OCT-2010 was vaccinated with the first 0.5 ml dose of MMR II (lot # 668015/0810Z) subcutaneously. Other suspect therapy included VARIVAX (MSD). Other concomitant therapy included PREVNAR. On 21-OCT-2010 the patient experienced rash and fever after receiving his first dose of MMR II. No lab/diagnostic studies were performed. The patient's rash and fever persisted. On an unspecified date the patient sought medical attention via office visit. The reporter requested a lot check for MMR II (lot # 668015/0810Z). A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. This is one of the several reports received from the same source. Additional information has been requested.
About 6 pm, started feeling aches and chills.  By 6:45 pm, had severe chills.
Pt received Pfizer vaccine 1st booster, stated feeling numbness and tingling sensation right after giving the vaccine.  Side effects was explain and pt. Verbalized understanding. I offered if she wanted medical help, pt declined. I asked pt to wait in the waiting area to observed. Pt stayed 20 mins in the area and verbalized that she will be going to her apartment.  Pt stated she felt a little better.
slight fever; tiredness; muscle aches; headache; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th January 2021 11:00, the patient received the 1st dose of Shingrix. On 13th January 2021, 1 days after receiving Shingrix, the patient experienced fever, tiredness, muscle pain and headache. On an unknown date, the outcome of the fever, tiredness, muscle pain and headache were not recovered/not resolved.   It was unknown if the reporter considered the fever, tiredness, muscle pain and headache to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrix, the patient experienced slight fever, tiredness, muscle aches and headache. The patient stated that, he/she expected this, but would like to know how long this might persist.
I am current diabetic and have a recent history (1 year ago) of muscular dystrophy. I use a cane to assist with mobility, and cannot lift my legs far to go up high stairs, nor lift my arms past my chest as a baseline.   Later in the evening/middle of the night, after the second shot, I got up around 3:30am to use the rest room and after each step, my knees, legs, hips, and arms gave out,  falling forward on my face and head. I had no strength to catch myself from falling, nor could I lift myself at all. Initially, I could not even roll over. It took 10 minutes with help from my wife to roll over, but I remained on the floor. I was on the bathroom floor/snake crawling for 2 hours trying to figure out ways I can get up, but I had no strength at all. After snake crawling to the bedroom, my wife called the paramedics to get me up at 530am, Tuesday April 6th.    Later that night of the 6th I did a little better, with help  I could sit up in the bed.  Overnight I tried to lift up to stand, and barely could stand, but my legs were too shaky, body bruised of course, and weak.   April 7th, the next day, I was able to sit up. Later that day I was able to get up to go to the bathroom with my wife?s help and the use of a rolling walker with wheels, brakes and a seat, about 3:50am this morning.  I have 35-40% of my strength, and can sit on the side of the bed. I need assistance to the bathroom and I have a ways to go to recover to my baseline.
At 2am, I woke up with 102 °  fever, chills, bodyaches, and headache. I was very tired all day Tuesday.
Pt recvd DTP/OPV/HIB on 28MAR91 & exp 6+ hrs of unconsolable crying w/high pitched cry; Info obtained @ 7OCT91 checkup, pt not seen for the above rxn;
Injection of expired; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EXPIRED PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "Injection of expired". Additional information: vaccine readmissions. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Reaction to my second dose of Moderna; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reaction to my second dose of Moderna) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction to my second dose of Moderna). At the time of the report, VACCINATION COMPLICATION (Reaction to my second dose of Moderna) outcome was unknown.            No Concomitant product use was reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Added reporter's Email address.
Feeling suddenly cold, then severe chills where entire body is shaking.  Also stomach upset with vomiting. This lasting for a few hours. Felt fine by morning.
pediatric patient received an adult dose; no adverse event; Information has been received from a registered nurse, regarding a 15-year-old patient (gender not provided). The patient's pertinent medical history, concurrent conditions, and concomitant therapies were not provided.  On 24-JUL-2020, the pediatric patient was vaccinated with an adult dose of Hepatitis A Vaccine, inactivated (VAQTA), 1 milliliter, lot # S030588 and expiration date 20-OCT-2020, (route not provided) for prophylaxis (product administered to patient of inappropriate age). The reporter stated that she had followed up with the patient's pediatrician who was not concerned with the dose. The patient was not experiencing any side effects.  This is one of two reports received from the same source.; Sender's Comments:  US-009507513-2007USA009968:
When I received the shot in my left arm my left arm became immediately sore down to my elbow. Shortly after this, my hand from my wrist down began shaking. My fingers were shaking and it was very noticeable, especially when drinking water with that hand. Additionally, the soreness stopped at my elbow and my arm from my elbow to my fingertips felt tingly, sometimes slightly numb, and it felt like it was vibrating even when it wasn't actively shaking. Additionally, my fingertips on my left hand, especially my ring fingertip hurt when touching things for the first few days. When I washed my hair it was especially noticeable. The pressure on my fingertips on that hand when washing my hair was painful to the touch. Now the shaking in my hand comes back on and off. There is still sometimes sensitivity in my left ring finger and my arm from my elbow down feels slightly asleep and quite frankly just "off."
That day I got the flu vaccine along with dose 4 of COVID-19, that same day about 2 hours later I got sick with the flu again, for a week, the following week I started to get hives on my stomach, legs , buttocks, face, lips, head, it itches a lot. I wanted to make an appointment with the doctor, but there was no one, they told me that if it was very serious I would go to the emergency room, but I didn't go. I am taking allergy pills and that has helped me.
I started having a sore throat and then I started to take a MUCINEX decongestant and cough medicine ROBITUSSIN DM. It felt more severe than a regular cold. I felt feverish but didn't have a high fever. I'm still feeling fatigued and congested but feeling better and sleeping good.
53 year old female given HINI nasal spray inadvertently.  Client had no risk factors.  No treatment was advised, per Dr.
Pt presented to clinic on 3/29/21 with dime-sized lesion on Right upper deltoid region. She stated that this was the injection site of her 2nd Moderna dose. The lesion was raised from the skin, hard to the touch (callous-like),